Nishi Whiteley is the author of Chronic Relief: A Guide to Cannabis for the Terminally & Chronically Ill. She is also the Director for Americas Business Development at the International Cannabis and Cannabinoids Institute. Prior to her current work she was a business development consultant and medical cannabis educator. Whitely also served as the director of international marketing at the Texas Department of Agriculture and was a fertilizers industry trends analyst for the Elsevier Group. Through her writing and speaking, Whiteley seeks to bridge the gap between cannabis science and safe application.
Scientists at the University of Louisville School of Medicine in Kentucky have identified a previously unknown molecular target of cannabidiol (CBD), which may have significant therapeutic implications for Parkinson’s Disease (PD).
Nishi Whiteley discusses the theme of cannabinoids and oxidation from her book “Chronic Relief: A Guide to Cannabis for the Terminally & Chronically Ill”. In the same way that paint protects metal from rusting or lemon juice protects apples from turning brown, cannabinoids protect our cells from oxidation.